The largest database of trusted experimental protocols

Dpscs

Manufactured by Merck Group
Sourced in United States, Germany

The DPSCs is a laboratory equipment product offered by Merck Group. It is designed for handling and processing differentiated primary human cells. The core function of the DPSCs is to facilitate the isolation, culture, and analysis of differentiated primary human cells for research and experimental purposes.

Automatically generated - may contain errors

2 protocols using dpscs

1

Osteogenic Differentiation of Dental Pulp Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human commercial cell line, DPSCs (Lonza, Basel, Switzerland) was used. For all studies examining the molecular mechanism of osteogenic differentiation, cells were seeded in 25 cm2 flasks and grown under a humidified atmosphere of 5% CO2 at 37 °C. Cells were precultured in DPSCs growth medium consisted of α-MEM (Merck Sigma-Aldrich, Darmstadt, Germany) supplemented with 2 mM GlutaMAX (Thermo Fisher Scientific, Waltham, MA, USA), 0.2 mM ascorbic acid 2-phosphate (Sigma-Aldrich), 10% fetal bovine serum (Biosera, Nuaille, France), 100 U/mL penicillin, and 100 µg/mL streptomycin (Biosera). The medium was replaced every three days. During preculture, cells remained in an undifferentiated stage. After reaching 80–90% confluence, cells were harvested using TrypLE Express Enzyme (Thermo Fisher Scientific) and then seeded at 5000 cells/cm2. When DPSCs reached 50% confluence (day 0), the growth medium was replaced with osteoinductive medium OsteoMAX-XF (Merck Sigma-Aldrich) for osteogenic differentiation and mineralization. The cells were grown in this specific medium for 24 days. In parallel, undifferentiated DPSCs (control) were cultured in the DPSCs growth medium. Media were changed every 3 days. Cell morphology was monitored during the experiment by light microscopy (Optika, Via Rigla, Italy).
+ Open protocol
+ Expand
2

Conditioned Medium from Dental Pulp Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DPSCs (Lonza, Walkersville, USA) were characterized by surface marker profiling (negative: CD34, CD45, and CD133; positive: CD105, CD166, CD29, CD90, and CD73) performed by the manufacturer. DPSCs at passage 6–8 were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich, Saint Louis, USA) supplemented with 10% fetal bovine serum (Bovogen, Melbourne, Australia) and 1% penicillin–streptomycin solution (Fujifilm Wako, Osaka, Japan) at 37 °C in 5% CO2 until 80% confluency. Subsequently, these cells were washed with phosphate-buffered saline (PBS; Fujifilm Wako, Osaka, Japan), and the culture medium was replaced with the vehicle medium (serum-free DMEM). After 48 h of incubation in 21% and 1% O2 (normoxic [N-] and hypoxic [H-] conditions, respectively), the cells were collected and centrifuged at 400 × g and 4 °C for 3 min. The supernatants were collected and centrifuged at 1700 × g and 4 °C for 3 min. Following this, the supernatants resulting from this centrifugation were collected and defined as N-CM or H-CM. CM was stored at − 80 °C before being used in the subsequent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!